Atlas Trials

Safety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected Patients

Clinical trial NCT01540240 · UNKNOWN

Trial details

NCT number
NCT01540240
Sponsor
University Hospital, Geneva
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
HIVZidovudine Adverse Reaction
Start date
2011-08-01
Primary completion
2012-12-01
Enrollment
136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.